Morgan Stanley’s AC Immune ACIU Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $148K | Buy |
|
|||||
|
2025
Q1 | $135K | Sell |
|
|||||
|
2024
Q4 | $450K | Buy |
|
|||||
|
2024
Q3 | $245K | Sell |
|
|||||
|
2024
Q2 | $314K | Sell |
|
|||||
|
2024
Q1 | $4.1M | Sell |
|
|||||
|
2023
Q4 | $17.6M | Buy |
|
|||||
|
2023
Q3 | $4.96M | Sell |
|
|||||
|
2023
Q2 | $5.2M | Sell |
|
|||||
|
2023
Q1 | $4.56M | Hold |
|
|||||
|
2022
Q4 | $3.98M | Sell |
|
|||||
|
2022
Q3 | $6.25M | Buy |
|
|||||
|
2022
Q2 | $7.11M | Sell |
|
|||||
|
2022
Q1 | $8.02M | Sell |
|
|||||
|
2021
Q4 | $11.1M | Buy |
|
|||||
|
2021
Q3 | $3.73M | Buy |
|
|||||
|
2021
Q2 | $2.12M | Buy |
|
|||||
|
2021
Q1 | $630K | Sell |
|
|||||
|
2020
Q4 | $818K | Buy |
|
|||||
|
2020
Q3 | $706K | Buy |
|
|||||
|
2020
Q2 | $513K | Buy |
|
|||||
|
2020
Q1 | $492K | Sell |
|
|||||
|
2019
Q4 | $631K | Sell |
|
|||||
|
2019
Q3 | $398K | Buy |
|
|||||
|
2019
Q2 | $395K | Sell |
|
|||||
|
2019
Q1 | $362K | Buy |
|
|||||
|
2018
Q4 | $267K | Sell |
|
|||||
|
2018
Q3 | $247K | Buy |
|
|||||
|
2018
Q2 | $270K | Sell |
|
|||||
|
2018
Q1 | $643K | Buy |
|
|||||
|
2017
Q4 | $747K | Buy |
|
|||||
|
2017
Q2 | – | Sell |
|
|||||
|
2017
Q1 | $20K | Sell |
|
|||||
|
2016
Q4 | $84K | Sell |
|
|||||
|
2016
Q3 | $211K | Buy |
|